Study guide

1.1 EBDVD Exam Format, Session Timing & Scoring Rules

UEMS European Board of Dermatovenereology Diploma Examination Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Eligibility & Examination Regulations

1.1 EBDVD Exam Format, Session Timing & Scoring Rules 1.2 Eligibility Routes, Application Requirements & Re-take Regulations 1.3 UEMS-EBDV Governance, European Training Requirements & Diploma Recognition

2 Chapter 2: Dermatologic Terminology, Lesion Morphology & Skin Biology

2.1 Skin Anatomy, Epidermal Biology & Barrier Function 2.2 Primary & Secondary Lesion Morphology 2.3 Cutaneous Immunology & Pathophysiological Reaction Patterns

3 Chapter 3: Dermatopathology & Diagnostic Procedures

3.1 Biopsy Selection, Processing & Special Staining Techniques 3.2 Major Histopathologic Patterns & Tissue Reaction Types 3.3 Direct & Indirect Immunofluorescence Microscopy

4 Chapter 4: Epidemiology, Photobiology & Occupational Dermatology

4.1 Epidemiological Principles & Cutaneous Disease Burden 4.2 Photobiology & Photoprotection 4.3 Occupational Dermatoses & Contact Sensitisation Surveillance

5 Chapter 5: Papulosquamous, Follicular & Adnexal Disease

5.1 Psoriasis: Variants, Psoriatic Arthritis, Comorbidity & European Management 5.2 Lichen Planus, Lichenoid Eruptions & Other Papulosquamous Disorders 5.3 Acne Vulgaris, Rosacea & Perioral Dermatitis 5.4 Hidradenitis Suppurativa, Hyperhidrosis & Other Sweat Gland Disorders

6 Chapter 6: Hair, Nails & Pigmentary Disorders

6.1 Hair Disorders: Non-Scarring & Scarring Alopecia, Hair Shaft Defects & Hirsutism 6.2 Nail Disorders, Onychomycosis & Nail Unit Tumours 6.3 Pigmentary Disorders: Vitiligo, Melasma & Other Hypo- and Hyperpigmentation

7 Chapter 7: Drug Reactions, Granulomatous & Deposition Disease and Skin Signs of Systemic Disease

7.1 Cutaneous Adverse Drug Reactions, SCARs & Dermatological Emergencies 7.2 Granulomatous & Deposition Disorders and Panniculitis 7.3 Skin Signs of Systemic Disease, Porphyrias, Nutritional Deficiency & Paraneoplastic Dermatoses

8 Chapter 8: Pruritus, Pregnancy & Geriatric Dermatology, Physical Injury and Mucosal Disease

8.1 Chronic Pruritus, Chronic Prurigo, Dermatoses of Pregnancy & Geriatric Dermatology 8.2 Burns, Cold, Heat & Radiation Injury and the Principles of Wound Healing 8.3 Oral Mucosal, Lip, Genital Mucosal & Perianal (Proctological) Disease

9 Chapter 9: Autoimmune Bullous Diseases

9.1 Pemphigus Group: Pemphigus Vulgaris, Foliaceus & Paraneoplastic Pemphigus 9.2 Pemphigoid Group & Epidermolysis Bullosa Acquisita 9.3 Dermatitis Herpetiformis & Linear IgA Bullous Dermatosis

10 Chapter 10: Eczematous Disorders, Urticaria & Allergology

10.1 Atopic Dermatitis: Pathogenesis, Phenotypes & European Management 10.2 Allergic & Irritant Contact Dermatitis: Pathogenesis, Investigation & Common Allergens 10.3 Urticaria, Angioedema & Cutaneous Mastocytosis 10.4 Immediate-Type Allergy: Diagnostics, Anaphylaxis, Food, Venom & Drug Allergy

11 Chapter 11: Connective Tissue Diseases & Cutaneous Vasculitis

11.1 Cutaneous Lupus Erythematosus Spectrum & Systemic Manifestations 11.2 Dermatomyositis, Systemic Sclerosis & Scleroderma Spectrum 11.3 Cutaneous Vasculitis & Neutrophilic Dermatoses

12 Chapter 12: Paediatric & Genetic Dermatology

12.1 Vascular Anomalies & Benign Neonatal Dermatoses 12.2 Hereditary Ichthyoses & Disorders of Keratinisation 12.3 Genodermatoses, Neurocutaneous Syndromes & Epidermolysis Bullosa

13 Chapter 13: Bacterial, Mycobacterial, Parasitic & Zoonotic Cutaneous Infections

13.1 Bacterial Skin & Soft Tissue Infections 13.2 Mycobacterial Infections: Cutaneous Tuberculosis, Leprosy & Atypical Mycobacteria 13.3 Parasitic Infestations, Arthropod Bites & Cutaneous Leishmaniasis 13.4 Lyme Borreliosis, Rickettsioses & Other Zoonotic and Travel-Related Skin Infections

14 Chapter 14: Viral & Fungal Cutaneous Infections

14.1 Herpesviridae Infections: HSV, VZV & HHV-8 14.2 Poxviruses & Human Papillomavirus Manifestations 14.3 Superficial, Subcutaneous & Deep Mycoses

15 Chapter 15: Sexually Transmitted Infections & Genital Infections

15.1 Syphilis: Pathogenesis, Clinical Stages, Serology & European Management 15.2 Neisseria gonorrhoeae, Chlamydia trachomatis & Genital Ulcer Diseases 15.3 HIV-Related Dermatoses, Partner Notification & Anogenital Lichen Sclerosus 15.4 Non-Gonococcal Urethritis, Mycoplasma genitalium, Trichomoniasis, Vaginal Infections & Balanitis

16 Chapter 16: Sexual Health Services, HIV Prevention & Anogenital Medicine

16.1 STI Epidemiology, Prevention, Services, Sexual History, HIV Testing, ART & PrEP/PEP 16.2 HPV-Related Anogenital Neoplasia, Cervical Screening & Common Gynaecological and Andrological Disorders 16.3 STIs in Pregnancy, Neonates & Children, Contraception, Sexual Health & Psychosexual Problems

17 Chapter 17: Keratinocyte Carcinomas, Precancerous Lesions & Other Skin Tumours

17.1 Actinic Keratoses, Bowen Disease & Field Cancerisation 17.2 Basal Cell Carcinoma: Subtypes, Risk Stratification & Management 17.3 Cutaneous Squamous Cell Carcinoma & Keratoacanthoma 17.4 Benign & Malignant Epidermal, Adnexal, Mesenchymal and Vascular Tumours, Cysts, Histiocytoses & Metastases

18 Chapter 18: Melanocytic Naevi & Melanoma

18.1 Benign Melanocytic Naevi: Acquired, Congenital, Spitz, Blue, Halo & Atypical Naevi 18.2 Melanoma Risk Factors, Clinical Presentation & Biopsy Protocol 18.3 Melanoma Histopathology, Breslow Thickness & Staging 18.4 Systemic Therapy for Advanced & Metastatic Melanoma

19 Chapter 19: Dermoscopy, Skin Imaging & Cutaneous Lymphomas

19.1 Dermoscopic Principles, Structures & Algorithmic Approaches 19.2 Dermoscopy of Non-Melanocytic Cutaneous Neoplasms 19.3 Non-Invasive Skin Imaging, Skin Function Measurement, Teledermatology & Skin Cancer Surveillance 19.4 Cutaneous Lymphomas, Merkel Cell Carcinoma & Cutaneous Sarcomas

20 Chapter 20: Dermatopharmacology, Systemic Therapeutics & Prescribing

20.1 Topical Corticosteroids, Calcineurin Inhibitors & Retinoids 20.2 Systemic Immunosuppressive & Biologic Therapies 20.3 Oral Retinoids & Phototherapy Modalities 20.4 Dermatological Prescribing: Anti-Infectives, Antihistamines, Antimalarials, Dapsone, Special Populations & Cutaneous Toxicity of Cancer Therapy

21 Chapter 21: Dermatosurgery, Cryotherapy, Lasers & Aesthetic Procedures

21.1 Surgical Anatomy, Local Anaesthesia & Excision Principles 21.2 Cutaneous Reconstructive Flaps, Skin Grafts & Surgical Complications 21.3 Cryosurgery, Electrosurgery & Cutaneous Lasers 21.4 Aesthetic & Corrective Dermatology, Photodynamic Therapy & Dermatological Radiotherapy

22 Chapter 22: Phlebology, Angiology, Psychodermatology & EBDVD Revision

22.1 Phlebology, Chronic Venous Insufficiency & Lower Extremity Ulcers 22.2 Angiology: Arterial Disease, Raynaud Phenomenon, Livedo, Thrombosis, Lymphoedema & Lipoedema 22.3 Psychodermatology, Delusional Infestation & Factitious Disorders 22.4 EBDVD Revision Strategy & Cross-Topic Review

1.1 EBDVD Exam Format, Session Timing & Scoring Rules

Key Takeaways Explain This Topic AI

The EBDVD is a single-day, computer-based examination of 200 single-best-answer multiple-choice questions, including a clinical slide collection, delivered in English (UEMS-EBDV).

The 2026 examination took place on 25 September 2026 as a hybrid online examination, taken on site in Frankfurt or remotely under approved invigilation (UEMS-EBDV).

The exam is divided into five sessions of 40 questions, each lasting 60 minutes, from 09:00 to 15:45 Central European Summer Time (UEMS-EBDV).

Each question scores 1 point, there is no negative marking, and candidates must reach at least 55% (22 of 40) in every one of the five sessions (UEMS-EBDV).

Results are announced within 3 weeks, and the computer-based examination is operated and scored by Orzone AB, Gothenburg, Sweden (UEMS-EBDV).

Last updated: September 2026

1.1 EBDVD Exam Format, Session Timing & Scoring Rules

About this guide: This study guide is written and published independently by ExamFinch to help candidates study for the EBDVD examination. It is not produced, reviewed, or endorsed by the UEMS or the UEMS European Board of Dermatovenereology (UEMS-EBDV). Exam facts in this chapter come from the official UEMS-EBDV examination page (last updated 3 April 2026), checked on 26 September 2026.

The UEMS European Board of Dermatovenereology Diploma (EBDVD) examination is described by the Board as "a test of excellence in Dermatology and Venereology". It assesses the knowledge and clinical skills needed to deliver a high standard of dermato-venereological care in hospitals and in independent practice. The UEMS-EBDV is responsible for the examination. Its Sub-commission for European Board Examination organises and delivers it.

Knowing the format matters because the pass rule is unusual. You must pass every session, so a weak area can fail you even if your overall score is high.

The Examination at a Glance

  • Feature Official Rule (2026 examination)
  • Date 25 September 2026 (one day)
  • Format Hybrid online examination: on site in Frankfurt am Main or remote from an approved, invigilated room
  • Questions 200 multiple-choice questions (MCQs) , including a clinical slide collection
  • Answer format Each question has one correct answer
  • Structure Five sessions of 40 questions , all on the same day
  • Session length 60 minutes per session
  • Language English only
  • Scoring 1 point per correct answer; no negative marking
  • Pass rule At least 55% in each of the five sessions
  • Delivery and scoring Computer-based online examination operated and scored by Orzone AB , Gothenburg, Sweden
  • Results Announced within 3 weeks

Questions may cover "any basic science, medical or surgical topic relevant to the practice of dermatovenereology". They sample the European curriculum published in the UEMS Training Requirements (see Section 1.3).

Official Session Timetable (CEST)

  • Time (CEST) Block Official Topics
  • 08:00–08:50 Registration Online registration and identity checks
  • 08:50–09:00 Introduction Instructions

09:00–10:00 Session 1 (40 MCQs) General Terminology, Dermatopathology, Epidemiology, Prevention, General Dermatology

  • 10:15–11:15 Session 2 (40 MCQs) General Dermatology, Bullous and Autoimmune Dermatoses, Eczema, Allergology
  • 11:30–12:30 Session 3 (40 MCQs) Infectious Diseases, STD/STI, Ano-genital Diseases
  • 13:30–14:30 Session 4 (40 MCQs) Dermato-Oncology, Dermoscopy

14:45–15:45 Session 5 (40 MCQs) Dermatopharmacology, Therapy, Dermato-Surgery, Phlebology, Angiology, Psychosomatics

The timetable leaves a 15-minute gap between most sessions and a one-hour break between Sessions 3 and 4. The Board states that the number of questions and topics per session can be changed, but not later than 1 month before the examination . Check the official page for the current year.

General Dermatology appears in both Session 1 and Session 2. Inflammatory skin disease is therefore tested in two separate pass/fail blocks.

Scoring: 55% in Every Session

Each correct answer earns 1 point. A wrong or blank answer earns nothing and does not cost a point. The pass mark is 55% in each session . With 40 questions per session:

55% × 40 = 22 correct answers needed in each session .

21 correct (52.5%) fails that session, however strong the other sessions are.

The total of 200 is not used to offset a failed session. There is no compensation between sessions.

Worked Example

  • Candidate S1 S2 S3 S4 S5 Total Outcome
  • A 22 23 22 24 22 113/200 (56.5%) Pass : 55% reached in all five sessions
  • B 38 36 39 37 21 171/200 (85.5%) Fail : Session 5 is below 22/40

Candidate B has a much higher total but fails. Under the retake rules (Section 1.2), a failed candidate retakes only the sessions not passed.

Practical Timing

With 60 minutes for 40 questions, the average is 90 seconds per question . That figure is simple arithmetic, not an official recommendation. Because there is no negative marking, never leave a question unanswered : a considered guess can only help.

Exam-Day Conduct Rules

The official instructions apply to on-site and remote candidates:

No mobile phones, wallets, notes, papers, textbooks, calculators, or other electronic devices at the desk.

Do not start until the invigilator gives the instructions, and do not copy, photograph, record, or note down any examination material.

No communication with other candidates until you leave the room. Questions cannot be discussed with invigilators; raise your hand to attract attention.

If you leave the room temporarily, an invigilator accompanies you.

Keystrokes are monitored by invigilators and by the examination software. A candidate suspected of cheating is disqualified immediately and the fee is forfeited.

At the end, stop working and submit the paper online. Leave only when the invigilator allows it.

Non-compliance with the rules leads to exclusion, and the fee is not returned.

On-Site versus Remote

Aspect On Site (Frankfurt) Remote

Venue University Hospital Frankfurt campus, Building 10A, basement, computer examination room P10-1, Theodor-Stern-Kai 7 A secure room (classroom, meeting or training room) in the candidate's hospital, a university, or a national professional association's headquarters

Invigilator Provided by UEMS-EBDV Designated by the head of the institution; one invigilator may supervise up to 10 candidates

Computer Candidates bring their own computer that meets the requirements Computer and phone with audio and video for remote monitoring; iPad-type devices are not allowed for online invigilation

  • Extra documents None Photo of the room and a signed Consent to Invigilate
  • Accommodation Arranged by the candidate Not applicable

Remote candidates may share a room, but they must not sit directly beside each other. They must be well separated or sit back to back. All candidates must attend a test meeting 1–2 weeks before the examination . At registration and at the test meeting, candidates show a passport or ID card to confirm identity and citizenship.

Loading diagram... Official 2026 EBDVD examination day (CEST)